CVRx, Inc.

NasdaqGS:CVRX

Sector

🏥 Health Care

Industries

🔬 Clinical Trials

🧬 Biotechnology

🏥 Hospitals & Clinics

🩺 Medical Instruments

💻 Telehealth

Location

United States

Market Cap

USD 151.74 M

Share Price

USD 5.82

Avg Daily Volume

421,031

Change (1 day)

-0.85%

Change (1 year)

-50.26%

Change (YTD)

-54.06%

CVRx, Inc. Market Capitalization on June 27, 2025: USD 151.74 M

CVRx, Inc. Market Capitalization is USD 151.74 M on June 27, 2025, a -42.73% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

CVRx, Inc. 52-week low Market Capitalization is USD 477.20 M on June 27, 2025, which is 214.48% above the current Market Capitalization.
CVRx, Inc. 52-week low Market Capitalization is USD 123.84 M on June 27, 2025, which is -18.38% below the current Market Capitalization.
CVRx, Inc. average Market Capitalization for the last 52 weeks is USD 257.69 M.

Daily

From:

To:

Zoom:

Key data

Date	Market Capitalization	Share Price	Share Price	Price to Earnings Ratio (P/E)

NasdaqGS: CVRX

CVRx, Inc.

CEO	Mr. Kevin Hykes
IPO Date	June 30, 2021
Location	United States
Headquarters	9201 West Broadway Avenue
Employees	206
Sector	🏥 Health Care
Industries Clinical Trials 🧬 Biotechnology 🏥 Hospitals & Clinics 🩺 Medical Instruments 💻 Telehealth

Description

CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The company sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, rest of Europe, and internationally. CVRx, Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.